Literature DB >> 20008208

Risk of future arterial cardiovascular events in patients with idiopathic venous thromboembolism.

David Green1.   

Abstract

Venous and arterial thromboses have traditionally been considered distinct pathophysiologic entities. However, the two disorders have many features in common, and there is evidence that persons with venous thrombosis may be at greater risk for arterial events. The pathogenesis of both disorders includes endothelial injury, platelet activation, elevated levels of intrinsic clotting factors and inflammatory markers, increased fibrinogen, and impaired fibrinolysis. In addition, older age, obesity, dyslipidemia, and smoking predispose to both venous and arterial thrombosis. While the evidence that arterial disease is a risk factor for venous thrombosis is inconclusive, arterial disease does appear to occur with a modestly increased frequency in patients with a history of venous thromboembolism. Reported odds ratios in such patients were 1.2 for myocardial infarction, 1.3 for stroke, 2.3 for carotid plaque, and 4.3 for coronary calcification. Of note, in persons under age 40 with unprovoked venous thrombosis, the odds ratio for acute myocardial infarction was as high as 3.9. In general, however, venous disease is considered to be a weak risk factor for arterial thrombosis, and the use of agents specifically targeted to the prevention of heart attack or stroke in the majority of persons with VTE cannot be recommended at present.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20008208     DOI: 10.1182/asheducation-2009.1.259

Source DB:  PubMed          Journal:  Hematology Am Soc Hematol Educ Program        ISSN: 1520-4383


  6 in total

Review 1.  [Aspirin and venous thromboses].

Authors:  K Schrör
Journal:  Internist (Berl)       Date:  2015-01       Impact factor: 0.743

2.  Family history of myocardial infarction is a risk factor for venous thromboembolism among whites but not among blacks.

Authors:  Fatima D Mili; W Craig Hooper; Cathy Lally; Harland Austin
Journal:  Clin Appl Thromb Hemost       Date:  2012-06-12       Impact factor: 2.389

3.  Atherosclerosis and Its Impact on the Outcomes of Patients with Deep Venous Thrombosis.

Authors:  Karsten Keller; Jürgen H Prochaska; Meike Coldewey; Sebastian Göbel; Volker H Schmitt; Omar Hahad; Alexander Ullmann; Markus Nagler; Heidrun Lamparter; Christine Espinola-Klein; Thomas Münzel; Philipp S Wild
Journal:  Life (Basel)       Date:  2022-05-14

4.  Inhibitory effects of Qushuanling Capsule () on thrombus formation and platelet aggregation in rats.

Authors:  Jie Xue; Ke-Ping Zhang; Lu-Jia Zhu; Mei-Lin Xie; Hong-Quan Zhang
Journal:  Chin J Integr Med       Date:  2012-09-21       Impact factor: 1.978

5.  Long-Term Effects of Unprovoked Venous Thromboembolism on Mortality and Major Cardiovascular Events.

Authors:  Wei-Ting Chang; Chia-Li Chang; Chung-Han Ho; Chon-Seng Hong; Jhi-Joung Wang; Zhih-Cherng Chen
Journal:  J Am Heart Assoc       Date:  2017-05-03       Impact factor: 5.501

6.  Interdisciplinary management of deep vein thrombosis during rehabilitation of acute rupture of the anterior cruciate ligament: a case report.

Authors:  Kenneth E Reckelhoff; Anthony Miller
Journal:  J Chiropr Med       Date:  2014-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.